Anamik Jhunjhunwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anamik Jhunjhunwala has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Jinhwan Kim
Department of Biomedical Engineering University of California Davis Davis California USA
2 shared publications - Kelsey P. Kubelick
Department of Biomedical Engineering, University of Virginia, Charlottesville, USA
2 shared publications - Stanislav Y. Emelianov
Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University School of Medicine Atlanta Georgia USA
2 shared publications - A. Thomas Read
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University
1 shared publication - Ana Maria Sandoval Castellanos
Department of Surgery, School of Medicine, University of California Davis, Sacramento, USA
1 shared publication - Anika D. Kulkarni
Department of Biomedical Engineering, University of California Davis, Davis, USA
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Advanced Functional Materials
Dual Nanoparticle Labeling Enables Magnet‐Assisted Delivery and Retention of Stem Cells with Longitudinal Photoacoustic Imaging
Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.
- 16 November 2026
- Published by Wiley in Advanced Functional Materials
Open AccessDual Nanoparticle Labeling Enables Magnet‐Assisted Delivery and Retention of Stem Cells with Longitudinal Photoacoustic Imaging
Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.
- 8 August 2025
- Published by Springer Nature in Biomedical Engineering Letters
- Vol. 15 (6) , 1085-1096
Nanoengineered cytotoxic T cells for photoacoustic image-guided combinatorial cancer therapy
This study aims to demonstrate that surface engineering of cytotoxic T cells with drug-loaded nanoparticles enhances nanoparticle delivery to induce a more potent combinatorial chemotherapeutic and immunotherapeutic effect, as well as enabling spatial tracking through the use of non-invasive, real-time ultrasound-guided photoacoustic imaging. Ovalbumin (OVA)-targeting OT-1 T cells were functionalized with doxorubicin-loaded, mesoporous silica-coated gold nanorods. In vitro toxicity and synergistic effects were assessed using antigen-matched OVA-expressing melanoma cells, while in vivo studies evaluated therapeutic efficacy. Ultrasound-guided photoacoustic imaging was employed to confirm the targeted delivery of the nanoengineered cells. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect.
- 8 August 2025
- Published by Springer Nature in Biomedical Engineering Letters
- Vol. 15 (6) , 1085-1096
Nanoengineered cytotoxic T cells for photoacoustic image-guided combinatorial cancer therapy
This study aims to demonstrate that surface engineering of cytotoxic T cells with drug-loaded nanoparticles enhances nanoparticle delivery to induce a more potent combinatorial chemotherapeutic and immunotherapeutic effect, as well as enabling spatial tracking through the use of non-invasive, real-time ultrasound-guided photoacoustic imaging. Ovalbumin (OVA)-targeting OT-1 T cells were functionalized with doxorubicin-loaded, mesoporous silica-coated gold nanorods. In vitro toxicity and synergistic effects were assessed using antigen-matched OVA-expressing melanoma cells, while in vivo studies evaluated therapeutic efficacy. Ultrasound-guided photoacoustic imaging was employed to confirm the targeted delivery of the nanoengineered cells. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect.
- Open Access
- 7 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.
- 7 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessMagnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.